News and events


New clinical trial results suggest chemotherapy drug may help with recurrent or advanced Chordoma

A team of researchers in the U.S. has reported encouraging results from a pilot study testing the chemotherapy drug pemetrexed (Alimta) for patients with recurrent or advanced chordoma. Of the 14 patients on the trial, 10 had their tumors stabilize or shrink (two had their tumors shrink by more than 30%), and the majority of the patients experienced symptomatic improvements. 

This data suggesting that pemetrexed can control or even shrink some chordoma tumors and improve patients’ quality of life is deeply encouraging, but the results need to be validated in more patients before pemetrexed becomes a standard treatment for chordoma. 

Read more about the study. 


Want to make a donation?

You are the reason we can keep providing our vital supprt and funding. Individual donations and gifts may be made directly to Chordoma UK and enhanced through GIFT AID. Your fundraising can benefit from Chordoma UK`s charitable status enabling donations to be made through the Gift Aid scheme directly to the Chordoma UK bank account.

Donate now

Join our Mailing List

Please sign up to follow our ongoing story and events.


How your donation is spent

There is little funding available for research into this relentless bone cancer mainly because it is relatively rare, occurring in only 1 in 800,000 of the population. Without a focused approach to raising money for research into chordoma, little will change quickly.

Find out more

Get in touch

If you have any questions about Chordoma UK, or would like to talk to someone about cancer, send us an email and we'll get back to you as soon as we can.

Contact us


We all support each other

To share experiences, ask questions or vent your emotions and find others who understand.

Join us here